Using Automated Heparin Protocols and CPOE to Reduce Errors
When the Joint Commission adopted a National Patient Safety Goal requiring hospitals to reduce the likelihood of patient harm from the use of anticoagulants, St. Clair Hospital in Pittsburgh, Pennsylvania, swiftly mobilized and seized the opportunity to improve patient care. In fall 2007, the 329-bed hospital collected and analyzed data on anticoagulant medication occurrences over the preceding 2 years.
Medication Reconciliation: A Survey of Community Pharmacies and Emergency Departments
In any given week, 4 out of every 5 U.S. adults will use prescription medicines, over-the-counter drugs, or dietary supplements. Poor communication of a patient’s medication-use history between community practitioners and emergency department personnel contributes to many adverse drug events and can be a potential source of harm to patients.
of NovaBay Pharmaceuticals’ (AMEX:NBY) Aganocide compounds were
presented during three poster sessions at the Association for Research
in Vision and Ophthalmology (ARVO) annual meeting in Ft. Lauderdale,
growing unit dose line. Both items are AHP exclusives—AHP is the only
barcoded unit dose offering in the marketplace.
Baxa Corporation, a leading provider of medical devices and systems
that automate pharmacy operations and increase patient safety, announced the release of DoseEdge TPN, the industry’s first product for
completely managing the workflow for automated TPN production.
Web-based software helps hospital document compliance practices consistently.
Practice Fusion announced the launch of its free e-prescribing system for physicians.
The short-acting, reversible anticoagulant heparin is widely used in hospitalized patients to prevent the development or extension of potentially life-threatening blood clots. However, numerous issues make the use of this high-risk agent particularly challenging and error-prone.